Section
Trials
Status changes on the public trial registry: what a sponsor has registered, and what state that entry is in. A registry record reports no result.
-
BrightGene updates two BGM0504 registry records on one day
A Phase 2 entry is now marked completed and a Phase 3 entry registered in Indonesia is marked active, not recruiting. Both were updated on 13 October 2026.
-
Sheba Medical Center marks a Phase 2 healthy ageing record completed
The ELITE entry, returned by the registry among records matching semaglutide, was last updated on 13 October 2026.
-
Lilly paediatric tirzepatide registry record updated as recruiting
The Phase 3 entry covering participants aged 6 to under 12 was last updated on 13 October 2026 and carries the status recruiting.
-
Lilly multi-agent liver disease record opens for recruitment
The Phase 3 SYNERGY-Outcomes entry covering adults with metabolic dysfunction-associated steatotic liver disease was updated on 8 October 2026.
-
Retatrutide outcomes record moves to active, not recruiting
The Phase 3 TRIUMPH-Outcomes entry, sponsored by Eli Lilly and Company, was last updated on 8 October 2026.
-
Novo Nordisk cagrilintide record moves to active, not recruiting
The Phase 3 entry covering adults living with overweight or obesity and type 2 diabetes was last updated on 7 October 2026.
-
Boehringer Ingelheim posts a survodutide record as not yet recruiting
The Phase 3 SYNCHRONIZE-START entry was last updated on 2 October 2026 and has not opened to enrolment.
-
Survodutide liver fibrosis record updated as recruiting
The Phase 3 LIVERAGE entry, sponsored by Boehringer Ingelheim, was last updated on 1 October 2026.
-
Novo Nordisk paediatric cagrilintide and CagriSema record opens for recruitment
The Phase 3 entry covering children and adolescents was last updated on 30 September 2026 and carries the status recruiting.